1-4 of 4
Toshiaki Shirai
Close
Sort by
Journal Articles

Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib

Yllka Latifi, Federico Moccetti, Melinda Wu, Aris Xie, William Packwood, Yue Qi, Koya Ozawa, Weihui Shentu, Eran Brown, Toshiaki Shirai, Owen J. McCarty, Zaverio Ruggeri, Javid Moslehi, Junmei Chen, Brian J. Druker, Jose A. López, Jonathan R. Lindner
Journal: Blood
Blood (2019) 133 (14): 1597–1606.
https://doi.org/10.1182/blood-2018-10-881557
Published: 2019
Includes: Multimedia, Supplemental data
Journal Articles

Antisense Oligonucleotide Targeting of Thrombopoietin Synthesis Reduces Platelet Count within the Hemostatic Range and Slows Progression of De Novo Mammary Carcinogenesis in the Mmtv-Pymt Mouse

Toshiaki Shirai, PhD, Alexey Revenko, PhD, Justin Tibbits, MS, Lisa M Coussens, PhD, Owen JT McCarty, PhD, Brett P. Monia, PhD, Andras Gruber, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 989.
https://doi.org/10.1182/blood-2018-99-114157
Published: 2018
Journal Articles

Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction

Nagaharu Tsukiji, Osamu Inoue, Mitsuru Morimoto, Norifumi Tatsumi, Hiroaki Nagatomo, Koji Ueta, Toshiaki Shirai, Tomoyuki Sasaki, Shimon Otake, Shogo Tamura, Toshiaki Tachibana, Masataka Okabe, Masanori Hirashima, Yukio Ozaki, Katsue Suzuki-Inoue
Journal: Blood
Blood (2018) 132 (11): 1167–1179.
https://doi.org/10.1182/blood-2017-12-823369
Published: 2018
Includes: Supplemental data
Journal Articles

Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2

Shogo Tamura, Katsue Suzuki-Inoue, Nagaharu Tsukiji, Toshiaki Shirai, Tomoyuki Sasaki, Makoto Osada, Kaneo Satoh, Yukio Ozaki
Journal: Blood
Blood (2016) 127 (13): 1701–1710.
https://doi.org/10.1182/blood-2015-08-663708
Published: 2016
Includes: Supplemental data